{"nct_id":"NCT02138422","title":"A Phase 3 Study to Evaluate Xilonix as an Anticancer Therapy in Patients With Symptomatic Colorectal Cancer","status":"COMPLETED","status_verified_date":"2021-02","start_date":"2014-07-31","start_date_type":"ACTUAL","primary_completion_date":"2015-11-30","primary_completion_date_type":"ACTUAL","completion_date":"2015-11-30","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["JNJ"]}